Antimicrobial chemotherapy and sustainable development: The past, the current trend, and the future

African Journal Biomedical Research

Volumn 11, Issue 3, 2008, Pages 235-250

  Okonko, I O ^a   Fajobi, E A ^b   Ogunnusi, T A ^c   Ogunjobi, A A ^c   Obiogbolu, C H ^c  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b Federal College of Wildlife Management   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Antimicrobials; Diseases; Microbial resistance

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIRETROVIRUS AGENT; CEFTIOFUR; CEPHALOSPORIN; CHLORAMPHENICOL; COTRIMAZINE; ENROFLOXACIN; GENTAMICIN; LINCOMYCIN; NEOMYCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; STREPTOMYCIN; SULFACHLORPYRIDAZINE; SULFANILAMIDE; TETRACYCLINE; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGRICULTURE; AMEBIASIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ANTIVIRAL SUSCEPTIBILITY; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOTECHNOLOGY; BRUCELLOSIS; DIARRHEA; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG USE; ENTEROCOCCAL INFECTION; EPIDEMIC; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; FEVER; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LUNG TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PENICILLIUM; PREVALENCE; REVIEW; SEXUAL EDUCATION; SEXUALLY TRANSMITTED DISEASE; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SUSTAINABLE DEVELOPMENT; TUBERCULOSIS; TYPHOID FEVER;

EID: 77949286378     PISSN: 11195096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Chadwick, D.J. and Goode, J. 1997. Antibiotic resistance: Origins, evolution, selection and spread. Ciba Foundation symposium. Chister, UK: John Wiley & Sons. 207:1-10
2. Chalker, J. 1995. Effect of a drug supply and cost sharing system on prescribing patterns and on utilization of health facilities, a controlled trial from heath posts in the hills of Nepal. Health policy and planning.10 (4):423-430
3. Davies, J. 1994. Inactivation and the dissemination of resistance genes. Science 264: 375-82
4. Demain, A.L. and Elander, R. P. .1999. The betalactam antibiotics: past, present, and future. Antonie Van Leeuwenhoek.75(1-2):5-19.
5. th edition. Blackwell, Oxford. Pp 564.
6. Dixon, B. 1994. Power unseen: how microbes rule the world. New York: WH Freeman.
7. Garrett, L. 1994. The coming plague: newly emerging diseases in a world out of balance. New York: Penguin Books.
8. Gold, H.S. and Moellering, R.C. Jr.1996. Antimicrobial-drug resistance. N. Engl J Med; 335(19):1445-53
9. Hagman, H.M. and Strausbaugh, L.J. 1996. Vancomycin-resistant enterococci: the 'superbug' scourge that's coming your way. Postgrad. Med; 99(5):62-71
10. Hoel, D. and Williams, D. N. 1997. Antibiotics: Past, present, and future-Unearthing nature's magic bullets. Postgraduate Medicine, Vol 101:1 January 1997
11. Holzman, D. (1998). Phage as antibacterial tool. Genetic Engineering News. 15 October, pp48.
12. Jacoby, G.A., and Archer, G.L. 1991. New mechanisms of bacterial resistance to antimicrobial agents. New England Journal of Medicine, 324 (9): 601-9.
13. Karam, J.D. 1994. Molecular biology of bacteriophage T4. Herridon, Va: ASM Press
14. Knudson, M., 1998. The Hunt is on: For New Ways to Overcome Bacterial Resistance novel antibiotics and phage therapy as answers to this problem IACFA Newsletter: May, Issue 52. Reprinted from MIT's Technology Review on the mechanism of antibiotic resistance Jan/Feb 1998, Vol 100:9
15. Lansang, M. 1990. Purchase of antibiotics without prescription in Manila, the Philippines, in appropriate choices and doses, Journal of Clinical Epidemiology 43:61-67
16. Lemonick, M.D. 1996. Guerrilla warfare. Time. Fall Special Issue: 59, 62
17. Levy, S.B. 1995. Antimicrobial resistance, a global perspective in Antimicrobial resistance, a Crisis in Health care, Jungkind et al.,(Eds), biology.(390),Plenum press.
18. Levy, S.B. 1998, The Challenge of Antibiotic resistance, Scientific American, New York 278(3):46-53.
19. Lin, E.C.C.; Goldstein, R.; and Syvanerr, M. 1984. Bacteria, Plasmids and phages. An Introduction to Molecular biology. Cambridge, Mass: Harvard Univ. press. Pp 538.
20. Lorch, A. 1999. "Bacteriophages: An alternative to antibiotics?" Biotechnology and Development Monitor, 39:14-17.
21. Macaden R, and Bhat P. 1985. The changing pattern of resistance to ampicillin and cotrimoxazole in Shigella serotypes in Bangalore, South India. J. Infectious Diseases, 152:1348.
22. Magner, L. A. 1992. History of medicine. New York: Marcel Dekker.
23. Meleney, F.L. 1947. Treatment of surgical infections by chemical and antibiotic agents. Postgrad. Med; 1(2):87-96
24. Murray, B. 1985. Increasing resistance to trimethroprim- sulphamethoxazle among isolates of Escherichia coli in Developing Countries, J. Infectious Diseases, 152: 1107-1113.
25. Ogundipe, G.A.T., Oluokun, S.B. and Esuruoso, G.O. 1989. The development and efficiency of the animal health information system in Nigeria. Preventive Vet. Med., 7:121-135.
26. Osterholm, M.T. 1996. Emerging infectious diseases: a real public health crisis? (Guest editorial) Postgrad Med; 100(5):15-26
27. th International Edition, pp 1212.
28. Prusiner, S.B. 1996. Molecular biology and Pathogenesis of Prion diseases. Trends In Biochemical Sciences, 21: 482-7.
29. Robinson, D. 1976. The miracle finders: the stories behind the most important breakthroughs in medicine. New York: David McKay.
30. Welch, H.G. 1984. Antibiotic resistance: a new kind of epidemic. Postgrad. Med; 76(6):63-6
31. Wenzel R. 1995. Control of Antibiotic resistant Organisms, Journal of Infectious Disease and Antimicrobial Agents, 12 (1): 47-48.
32. White David G, Michael Moen and Darren Huber (1999) Trends in antibiotic resistance associated with E. coli calf scours. Alliance For The Prudent Use Of Antibiotics Department of Veterinary and Microbiological Sciences, North Dakota State University, Fargo, North Dakota, USA
33. World Bank 1995. Vietnam, poverty assessment and strategy, World Bank Country Operation Division, Country Department East Asia and Pacific Regions, January 1995.
34. World Health Organization (WHO).1993. How to investigate drug use in health facilities, WHO/DAP/93.1
35. World Health Organization, WHO (1999). Combating the growth of resistance to antibiotics. http://www.who.int/dap-icium/posters/2E1-txtf.html